NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
26.67
-1.16 (-4.17%)
At close: Aug 13, 2026, 4:00 PM EDT
27.20
+0.53 (1.99%)
After-hours: Aug 13, 2026, 7:34 PM EDT
NAMS Market Cap
NAMS has a market cap or net worth of $3.19 billion as of August 13, 2026. Its market cap has increased by 13.22% in one year.
Market Cap
3.19B
Enterprise Value
2.51B
1-Year Change
13.22%
Ranking
Category
Stock Price
$26.67
ChartMarket Cap Chart
Since February 8, 2021, NAMS's market cap has increased from $154.45M to $3.19B, an increase of 1,964.14%. That is a compound annual growth rate of 73.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2026 | 3.19B | -19.85% |
| Dec 31, 2025 | 3.98B | 44.58% |
| Dec 31, 2024 | 2.75B | 199.19% |
| Dec 29, 2023 | 919.56M | 3.44% |
| Dec 30, 2022 | 889.00M | 537.58% |
| Dec 31, 2021 | 139.43M | -9.72% |
| Feb 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AbCellera Biologics | 3.36B |
| Celldex Therapeutics | 3.35B |
| uniQure | 3.26B |
| Arcutis Biotherapeutics | 3.25B |
| MBX Biosciences | 3.23B |
| Alumis | 3.11B |
| Disc Medicine | 3.07B |
| Tarsus Pharmaceuticals | 3.02B |